Guardant Health (GH) Short Interest
Nasdaq • GH • US40131M1099
As of Oct 22, 2026, ORTEX estimated 9% of free float sold short, 6.7 days to cover, cost to borrow 0.4%. Sign up for live short interest data.
Nasdaq • GH • US40131M1099
As of Oct 22, 2026, ORTEX estimated 9% of free float sold short, 6.7 days to cover, cost to borrow 0.4%. Sign up for live short interest data.
This page tracks how heavily Guardant Health (Nasdaq:GH) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Guardant Health (Nasdaq: GH) has a market capitalization of $20.41B. Last close $150.87 (as of 2026-11-09); 52-week range $74.55 to $191.05. ORTEX data as of 2026-10-22: short interest was 9.03% of free float, 6.7 days to cover and the average cost to borrow was 0.4%. Sign up for live short interest data.